Document is current
Any future updates will be listed below
-
Authors
Elovitz, Michal A. https://orcid.org/0000-0001-7554-7180
Gee, Elaine P. S. https://orcid.org/0000-0001-7453-4433
Delaney-Busch, Nathaniel https://orcid.org/0000-0002-2187-6867
Moe, Alison B.
Reddy, Mitsu
Khodursky, Arkady
La, Johnny
Abbas, Ilma
Mekaru, Kay
Collins, Hunter
Siddiqui, Farooq
Nolan, Rory
Boelig, Rupsa C.
Kiefer, Daniel G. https://orcid.org/0000-0001-6136-1086
Simmons, Pamela M. https://orcid.org/0009-0007-4888-4609
Saade, George R.
Saad, Antonio
Carter, Ebony B.
McElrath, Thomas F. https://orcid.org/0000-0003-0857-0107
Quake, Stephen R.
DePristo, Mark A.
Haverty, Carrie
Lee, Manfred
Namsaraev, Eugeni
Berghella, Vincenzo
Collier, Ai-ris Y. https://orcid.org/0000-0002-8539-3960
Frolova, Antonia I. https://orcid.org/0000-0002-6491-6910
Park-Hwang, Esther
Pacheco, Luis D.
Sutton, Elizabeth F.
Jain, Maneesh
Rood, Kara
Grobman, William A.
Biggio, Joseph R.
Gyamfi-Bannerman, Cynthia
Jeyabalan, Arun
Rasmussen, Morten https://orcid.org/0000-0002-2743-5683
- License Information
-
More Information
Article History
Received: 8 November 2024
Accepted: 10 March 2025
First Online: 8 April 2025
Competing interests
: M.A.E., E.P.S.G, N.D.-B., A.B.M., M. Reddy, A.K., J.L., I.A., K.M., H.C., F.S., R.N., T.F.M., S.R.Q., M.A.D., C.H., M.L., E.N., M.J. and M. Rasmussen have an equity interest in Mirvie. Mirvie Inc. provided funding for the study. The following patents and patent applications cover various aspects described in the manuscript, including detecting presence or elevated risk of pregnancy complications such as preeclampsia in a pregnant subject based on differential expression of RNA markers: US Patent No 11,208,693 (Mirvie Inc, M.J., E.N., M.Rasmussen, F.S., M.Reddy), US Application No. 18/167,322 (Mirvie Inc, M.J., E.N., M.Rasmussen, F.S., M.Reddy, E.P.S.G, A.K., R.N., M.L.), and International Application No PCT/US2024/027,444 (Mirvie Inc, M.J., E.N., M.Rasmussen, F.S., M.Reddy, E.P.S.G., A.K., R.N., M.L., N.D.-B.). The remaining authors declare no competing interests.
